Literature DB >> 2482525

Structural features of Borrelia burgdorferi--the Lyme disease spirochete: silver staining for nucleic acids.

C F Garon1, D W Dorward, M D Corwin.   

Abstract

Borrelia burgdorferi--the Lyme disease spirochete--was grown in modified Kelly medium and characterized by transmission and by scanning electron microscopy. Using silver staining procedures which preferentially bind to nuclear components of eukaryotic cells, signal could be detected by backscattered electron imaging throughout the length of the prokaryotic spirochete. Interestingly, however, the highest levels of backscattered signal were observed in naturally elaborated membrane blebs that were visible attached to cell surfaces and free in the medium. These membrane vesicles could be enriched by filtration through nitrocellulose or Anopore membranes and by differential centrifugation. The possibility of contaminating cellular DNA coating the membrane vesicles was ruled out by exhaustive digestion with pancreatic DNAse I. Intact DNA was demonstrated both by lysing blebs directly on the surface of microscope grids and by extracting molecules from purified bleb preparation with detergents and solvents. Both linear and circular DNA molecules could be identified in purified membrane blebs. A simple, one-step, alternative silver staining procedure is described which appears to effectively label the protein-nucleic acid complexes contained in the membrane vesicles of the human pathogen B. burgdorferi, and may provide an important method to track and to define the biological function of these structures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482525

Source DB:  PubMed          Journal:  Scanning Microsc Suppl        ISSN: 0892-953X


  31 in total

1.  The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids.

Authors:  T Kitten; A G Barbour
Journal:  Genetics       Date:  1992-10       Impact factor: 4.562

2.  Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system.

Authors:  Nilay Sethi; Marie Sondey; Yunhong Bai; Kwang S Kim; Diego Cadavid
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

3.  DNA Is Packaged within Membrane-Derived Vesicles of Gram-Negative but Not Gram-Positive Bacteria.

Authors:  D W Dorward; C F Garon
Journal:  Appl Environ Microbiol       Date:  1990-06       Impact factor: 4.792

4.  Linear- and circular-plasmid copy numbers in Borrelia burgdorferi.

Authors:  J Hinnebusch; A G Barbour
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

5.  Lectin-binding characteristics of a Lyme borreliosis spirochete Borrelia burgdorferi sensu stricto.

Authors:  M Vancová; J Nebesárová; L Grubhoffer
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

6.  mRNA transcript distribution bias between Borrelia burgdorferi bacteria and their outer membrane vesicles.

Authors:  Anjali Malge; Vikas Ghai; Panga Jaipal Reddy; David Baxter; Taek-Kyun Kim; Robert L Moritz; Kai Wang
Journal:  FEMS Microbiol Lett       Date:  2018-07-01       Impact factor: 2.742

7.  Borrelia burgdorferi vesicle production occurs via a mechanism independent of immunoglobulin M involvement.

Authors:  R J Shoberg; D D Thomas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Virulent strain associated outer membrane proteins of Borrelia burgdorferi.

Authors:  J T Skare; E S Shang; D M Foley; D R Blanco; C I Champion; T Mirzabekov; Y Sokolov; B L Kagan; J N Miller; M A Lovett
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants.

Authors:  V P Mursic; G Wanner; S Reinhardt; B Wilske; U Busch; W Marget
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

10.  Interactions between extracellular Borrelia burgdorferi proteins and non-Borrelia-directed immunoglobulin M antibodies.

Authors:  D W Dorward; E D Huguenel; G Davis; C F Garon
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.